Predilife S.A. (FRA:0GA)
Germany · Delayed Price · Currency is EUR 3.150
-0.010 (-0.32%)
At close: Jan 9, 2026
Predilife Company Description
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses.
The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice.
It also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software.
Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Predilife S.A.
| Country | France |
| Founded | 2004 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 20 |
| CEO | Stephane Ragusa |
Contact Details
Address: 39 Rue Camille Desmoulins Villejuif, 94805 France | |
| Phone | 33 9 72 22 67 08 |
| Website | predilife.com |
Stock Details
| Ticker Symbol | 0GA |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Stephane Ragusa | Chief Executive Officer |